vela

Claim

Reducing anti-TfR antibody affinity for transferrin receptor enhances receptor-mediated transcytosis and brain uptake; bispecific anti-TfR/BACE1 antibody lowers brain Aβ in mice after single systemic dose. Mechanistic foundation of the Brain Shuttle delivery class.

Yichao Yu et al. 2011, Science Translational Medicine

← frontier · vf_a0f9919e6d163b8d
Confidence high · 0.74
Evidence experimental
Conditions in vivo
Created 2026-05-06

Evidence span

Reducing anti-TfR antibody affinity for transferrin receptor enhances receptor-mediated transcytosis and brain uptake; bispecific anti-TfR/BACE1 antibody lowers brain Aβ in mice after single systemic dose. Mechanistic foundation of the Brain Shuttle delivery class.

From Yichao Yu et al. 2011, Science Translational Medicine

Method & conditions

Evidence type
experimental
Method
manual state transition; control details require source inspection
Species
source-reported model organism
Conditions
Mouse PK/PD; TfR-bispecific anti-BACE1 antibody. Affinity-engineered for transcytosis kinetics.
Replicated
not yet

Confidence basis

operator-supplied frontier prior; review required